Encorafenib in combination with Cetuximab in BRAFV600E–Mutated Metastatic Colorectal Cancer: A European pooled analysis of observational studies

Encorafenib in combination with Cetuximab in BRAFV600E–Mutated Metastatic Colorectal Cancer: A European pooled analysis of observational studies

Encorafenib in combination with Cetuximab in BRAFV600E–Mutated Metastatic Colorectal Cancer: A European pooled analysis of observational studies

Hide study title

How is the study conducted?

dsesfre

Who can take part in the trial ?

dsesfre

What are the objectives of the trial and how are they evaluated ?

dsesfre

What is the study Medication ?

dsesfre

More information

dsesfre

Results

Study primary results :

EU Clinical Trial Register

EU Clinical Trial Register

THE RESULTS

https://doi.org/10.1111/jocd.12541

Publication :

https://doi.org/10.1111/jocd.12541